Clinical pharmacology and pharmacogenetics of thiopurines

S Sahasranaman, D Howard, S Roy - European journal of clinical …, 2008 - Springer
The thiopurine drugs—azathioprine (AZA), 6-mercaptopurine (6-MP), and thioguanine—are
widely used to treat malignancies, rheumatic diseases, dermatologic conditions …

Glutathione S-transferases: an overview in cancer research

G Di Pietro, LAV Magno… - Expert opinion on drug …, 2010 - Taylor & Francis
Importance of the field: The Glutathione S-transferases (GSTs) have advanced beyond the
classic view of their role in metabolism and are encouraging scientists to assess new …

Clinical pharmacogenetics and potential application in personalized medicine

SF Zhou, Y Ming Di, E Chan, YM Du… - Current drug …, 2008 - ingentaconnect.com
The current 'fixed-dosage strategy'approach to medicine, means there is much inter-
individual variation in drug response. Pharmacogenetics is the study of how inter-individual …

Azathioprine and 6‐mercaptopurine pharmacogenetics and metabolite monitoring in inflammatory bowel disease

RB Gearry, ML Barclay - Journal of gastroenterology and …, 2005 - Wiley Online Library
The thiopurine drugs azathioprine and 6‐mercaptopurine (6‐MP) are well‐established in the
treatment of inflammatory bowel disease (IBD). However, there is a wide inter‐and intra …

Azathioprine in dermatology: the past, the present, and the future

AA Patel, RA Swerlick, CO McCall - Journal of the American Academy of …, 2006 - Elsevier
For several decades, dermatologists have utilized azathioprine to treat numerous
debilitating skin diseases. This synthetic purine analog is derived from 6-mercaptopurine. It …

Population pharmacogenomics: an update on ethnogeographic differences and opportunities for precision public health

Y Zhou, VM Lauschke - Human Genetics, 2022 - Springer
Both safety and efficacy of medical treatment can vary depending on the ethnogeographic
background of the patient. One of the reasons underlying this variability is differences in …

the benefits of pharmacogenetics for improving thiopurine therapy in inflammatory bowel disease

L Chouchana, C Narjoz, P Beaune… - Alimentary …, 2012 - Wiley Online Library
Aliment Pharmacol Ther 2012; 35: 15–36 Summary Background Thiopurines represent an
effective and widely prescribed therapy in inflammatory bowel disease (IBD). Concerns …

Lack of Association between the C3435T Polymorphism in the Human Multidrug Resistance (MDR1) Gene and Response to Antiepileptic Drug Treatment

GJ Sills, R Mohanraj, E Butler, S McCrindle… - …, 2005 - Wiley Online Library
Purpose: P‐glycoprotein (P‐gp) has been implicated in the causation of refractory epilepsy.
The expression and efflux efficiency of P‐gp is influenced by a polymorphism (C3435T) in …

Worldwide distribution of NAT2 diversity: Implications for NAT2 evolutionary history

A Sabbagh, A Langaney, P Darlu, N Gérard… - BMC genetics, 2008 - Springer
Abstract Background The N-acetyltransferase 2 (NAT2) gene plays a crucial role in the
metabolism of many drugs and xenobiotics. As it represents a likely target of population …

Genetic polymorphisms of drug-metabolising enzymes and drug transporters in the chemotherapeutic treatment of cancer

TM Bosch, I Meijerman, JH Beijnen… - Clinical …, 2006 - Springer
There is wide variability in the response of individuals to standard doses of drug therapy.
This is an important problem in clinical practice, where it can lead to therapeutic failures or …